Compare

EMS-CHEMIE HOLDING AG/Fr. EMSN

1D1W1M3M6MYTD1Y5YMAX

About EMS-CHEMIE HOLDING AG

EMS-CHEMIE HOLDING AG is a Swiss-based company primarily operating in the chemicals industry. It specializes in the development, manufacturing, and sale of high-performance polymers and specialty chemicals. The company's core segments include Performance Polymers and Specialty Chemicals, catering to automotive, industrial, and consumer goods markets. Founded in 1936, EMS-CHEMIE has established its headquarters in Domat/Ems, Switzerland. A key strategic advantage of the company is its focus on innovative polymer solutions, which enables it to cater to diverse industrial needs efficiently.
Ticker
Fr. EMSN
Sector
Materials
Primary listing
XSWX
Employees
2,617
Headquarters
Domat/Ems, Switzerland

EMSN Metrics

BasicAdvanced
CHF 20B
41.70
CHF 20.28
0.81
CHF 18.40
1.73%

What the Analysts think about EMSN

Analyst ratings (Buy, Hold, Sell) for EMS-CHEMIE HOLDING AG stock.
Analyst projections of the future price of EMS-CHEMIE HOLDING AG stock.

Bulls say / Bears say

EMS has shown unusual earnings resilience in a difficult market. First-half EBIT rose 4.4% to CHF 309 million and the EBIT margin widened to 30.6%, helped by high-margin specialties, innovation and cost discipline. (EMS Group)
The company is gaining traction in structural growth applications rather than relying only on broad industrial demand. Metal-replacement and energy-saving solutions are in strong demand, while new projects in electric cars, robotics and data centres could expand the addressable market. (EMS Group, MarketScreener)
Shareholder returns remain a clear support for the investment case. The AGM approved a total 2026 dividend of CHF 18.40 per share, above the prior year's CHF 17.25, while first-half net income also increased 2.5%. (Vermögenszentrum, EMS Group)
The stronger Swiss franc is masking underlying progress in reported results: first-half sales fell 0.9% in francs even though local-currency sales rose 4.3%. EMS still expects full-year sales to be below 2025 because of currency effects. (EMS Group)
Growth is not broad-based across the portfolio. First-half High Performance Polymers sales slipped 0.3% and Specialty Chemicals sales fell 6.0% in francs, while management continues to describe the industrial economy as weak. (EMS Group)
The shares appear to price in a strong recovery already. A recent valuation review put EMS-CHEMIE on roughly 39 times earnings, well above its peer and wider European chemicals averages, leaving less room for disappointment if growth or margins weaken. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.

EMSN Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

EMSN Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing EMSN

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.